Many modifications lead to changes in the physicochemical properties of proteins, which can lead to inconsistent, underperforming drug products. This is why it’s essential to use a protein services provider you can trust.
Besides deamidation, oxidation and glycosylation, we have strong experience in looking at several other types of post-translational modifications. They can be roughly classified into two groups:
We observe and investigate all modifications by using our fully developed advanced research methodologies, which usually includes RP-HPLC, intact mass determination or peptide mapping. In addition, we can either screen the samples for possible modifications or we can develop a specific test to identify and possibly quantify them.
Characterizing all protein modifications is a key requirement of ICH Q6B.
![]() |
Dr Katja AschermannHead of Business Development Protein Services. Phone: +49 (0) 231 9742-6300 |